Europe Recombinant Human Insulin Industry 2016 Deep Market Research Report
- QYR418793
- 135 Pages
- February 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Human Insulin market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Human Insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 154 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Recombinant Human Insulin
1.2 Classification of Recombinant Human Insulin
1.3 Applications of Recombinant Human Insulin
1.4 Industry Chain Structure of Recombinant Human Insulin
1.5 Industry Overview of Recombinant Human Insulin
1.6 Industry Policy Analysis of Recombinant Human Insulin
1.7 Industry News Analysis of Recombinant Human Insulin
2 Manufacturing Cost Structure Analysis of Recombinant Human Insulin
2.1 Bill of Materials (BOM) of Recombinant Human Insulin
2.2 BOM Price Analysis of Recombinant Human Insulin
2.3 Labor Cost Analysis of Recombinant Human Insulin
2.4 Depreciation Cost Analysis of Recombinant Human Insulin
2.5 Manufacturing Cost Structure Analysis of Recombinant Human Insulin
2.6 Manufacturing Process Analysis of Recombinant Human Insulin
2.7 Europe Price, Cost and Gross of Recombinant Human Insulin 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Europe Key Recombinant Human Insulin Manufacturers in 2015
3.3 R&D Status and Technology Source of Europe Recombinant Human Insulin Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Europe Recombinant Human Insulin Key Manufacturers in 2015
4 Production Analysis of Recombinant Human Insulin by Regions, Type, and Applications
4.1 Europe Production of Recombinant Human Insulin by Regions 2011-2016
4.2 Europe Production of Recombinant Human Insulin by Type 2011-2016
4.3 Europe Sales of Recombinant Human Insulin by Applications 2011-2016
4.4 Price Analysis of Europe Recombinant Human Insulin Key Manufacturers in 2015
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Recombinant Human Insulin 2011-2016
5 Consumption Volume and Consumption Value Analysis of Recombinant Human Insulin by Regions
5.1 Europe Consumption Volume of Recombinant Human Insulin by Regions 2011-2016
5.2 Europe Consumption Value of Recombinant Human Insulin by Regions 2011-2016
5.3 Europe Consumption Price Analysis of Recombinant Human Insulin by Regions 2011-2016
6 Analysis of Recombinant Human Insulin Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Recombinant Human Insulin 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Recombinant Human Insulin 2014-2015
6.3 Sales Overview of Recombinant Human Insulin 2011-2016
6.4 Supply, Consumption and Gap of Recombinant Human Insulin 2011-2016
6.5 Import, Export and Consumption of Recombinant Human Insulin 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Recombinant Human Insulin 2011-2016
7 Analysis of Recombinant Human Insulin Industry Key Manufacturers
7.1 Novo Nordisk
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Novo Nordisk SWOT Analysis
7.2 Eli Lilly
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Eli Lilly SWOT Analysis
7.3 Bioton
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Bioton SWOT Analysis
7.4 Dongbao
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Dongbao SWOT Analysis
7.5 United Laboratories (TUL)
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 United Laboratories (TUL) SWOT Analysis
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Recombinant Human Insulin Product Types
8.5 Market Share Analysis of Different Recombinant Human Insulin Price Levels
8.6 Gross Margin Analysis of Different Recombinant Human Insulin Applications
9 Marketing Trader or Distributor Analysis of Recombinant Human Insulin
9.1 Marketing Channels Status of Recombinant Human Insulin
9.2 Traders or Distributors of Recombinant Human Insulin with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Recombinant Human Insulin
9.4 Europe Import, Export and Trade Analysis of Recombinant Human Insulin
10 Development Trend of Recombinant Human Insulin Industry 2016-2021
10.1 Capacity and Production Overview of Recombinant Human Insulin 2016-2021
10.2 Production Market Share by Product Types of Recombinant Human Insulin 2016-2021
10.3 Sales and Sales Revenue Overview of Recombinant Human Insulin 2016-2021
10.4 Europe Sales of Recombinant Human Insulin by Applications 2016-2021
10.5 Import, Export and Consumption of Recombinant Human Insulin 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Recombinant Human Insulin 2016-2021
11 Industry Chain Suppliers of Recombinant Human Insulin with Contact Information
11.1 Major Raw Materials Suppliers of Recombinant Human Insulin with Contact Information
11.2 Manufacturing Equipment Suppliers of Recombinant Human Insulin with Contact Information
11.3 Major Players of Recombinant Human Insulin with Contact Information
11.4 Key Consumers of Recombinant Human Insulin with Contact Information
11.5 Supply Chain Relationship Analysis of Recombinant Human Insulin
12 New Project Investment Feasibility Analysis of Recombinant Human Insulin
12.1 New Project SWOT Analysis of Recombinant Human Insulin
12.2 New Project Investment Feasibility Analysis of Recombinant Human Insulin
13 Conclusion of the Europe Recombinant Human Insulin Industry 2016 Market Research Report
Figure Picture of Recombinant Human Insulin
Table Product Specifications of Recombinant Human Insulin
Table Classification of Recombinant Human Insulin
Figure Europe Sales Market Share of Recombinant Human Insulin by Product Types in 2015
Table Applications of Recombinant Human Insulin
Figure Europe Sales Market Share of Recombinant Human Insulin by Applications in 2015
Figure Industry Chain Structure of Recombinant Human Insulin
Table Europe Industry Overview of Recombinant Human Insulin
Table Industry Policy of Recombinant Human Insulin
Table Industry News List of Recombinant Human Insulin
Table Bill of Materials (BOM) of Recombinant Human Insulin
Table Bill of Materials (BOM) Price of Recombinant Human Insulin
Table Labor Cost of Recombinant Human Insulin
Table Depreciation Cost of Recombinant Human Insulin
Table Manufacturing Cost Structure Analysis of Recombinant Human Insulin in 2015
Figure Manufacturing Process Analysis of Recombinant Human Insulin
Table Europe Price Analysis of Recombinant Human Insulin 2011-2016 (USD/Dose)
Table Europe Cost Analysis of Recombinant Human Insulin 2011-2016 (USD/Dose)
Table Europe Gross Analysis of Recombinant Human Insulin 2011-2016
Table Capacity (K Doses) and Commercial Production Date of Europe Recombinant Human Insulin Key Manufacturers in 2015
Table Manufacturing Plants Distribution of Europe Key Recombinant Human Insulin Manufacturers in 2015
Table R&D Status and Technology Source of Europe Recombinant Human Insulin Key Manufacturers in 2015
Table Raw Materials Sources Analysis of Europe and Europe Recombinant Human Insulin Key Manufacturers in 2015
Table Europe Production of Recombinant Human Insulin by Regions 2011-2016 (K Doses)
Table Europe Production Market Share of Recombinant Human Insulin by Regions 2011-2016
Figure Europe Production Market Share of Recombinant Human Insulin by Regions in 2014
Figure Europe Production Market Share of Recombinant Human Insulin by Regions in 2015
Table Europe Production of Recombinant Human Insulin by Types in 2011-2016 (K Doses)
Table Europe Production Market Share of Recombinant Human Insulin by Type in 2011-2016
Figure Europe Production Market Share of Recombinant Human Insulin by Type in 2014
Figure Europe Production Market Share of Recombinant Human Insulin by Type in 2015
Table Europe Sales of Recombinant Human Insulin by Applications 2011-2016 (K Doses)
Table Europe Production Market Share of Recombinant Human Insulin by Applications 2011-2016
Figure Europe Production Market Share of Recombinant Human Insulin by Applications in 2014
Figure Europe Production Market Share of Recombinant Human Insulin by Applications in 2015
Table Price Comparison of Europe Recombinant Human Insulin Key Manufacturers in 2015 (USD/Dose)
Table Europe Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Recombinant Human Insulin 2011-2016
Table Europe Consumption Volume of Recombinant Human Insulin by Regions 2011-2016 (K Doses)
Table Europe Consumption Volume Market Share of Recombinant Human Insulin by Regions 2011-2016
Figure Europe Consumption Volume Market Share of Recombinant Human Insulin by Regions in 2014
Figure Europe Consumption Volume Market Share of Recombinant Human Insulin by Regions in 2015
Table Europe Consumption Value of Recombinant Human Insulin by Regions 2011-2016 (M USD)
Table Europe Consumption Value Market Share of Recombinant Human Insulin by Regions 2011-2016
Figure Europe Consumption Value Market Share of Recombinant Human Insulin by Regions in 2014
Figure Europe Consumption Value Market Share of Recombinant Human Insulin by Regions in 2015
Table Consumption Price of Recombinant Human Insulin by Regions 2011-2016 (USD/Dose)
Table Europe and Major Manufacturers Capacity of Recombinant Human Insulin 2011-2016 (K Doses)
Table Europe Capacity Market Share of Major Recombinant Human Insulin Manufacturers 2011-2016
Table Europe and Major Manufacturers Production of Recombinant Human Insulin 2011-2016 (K Doses)
Table Europe Production Market Share of Major Recombinant Human Insulin Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales of Recombinant Human Insulin 2011-2016 (K Doses)
Table Europe Sales Market Share of Major Recombinant Human Insulin Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales Revenue of Recombinant Human Insulin 2011-2016 (M USD)
Table Europe Sales Revenue Market Share of Major Recombinant Human Insulin Manufacturers 2011-2016
Figure Europe Capacity (K Doses), Production (K Doses) and Growth Rate of Recombinant Human Insulin 2011-2016
Figure Europe Capacity Utilization Rate of Recombinant Human Insulin 2011-2016
Figure Europe Sales Revenue (M USD) and Growth Rate of Recombinant Human Insulin 2011-2016
Figure Europe Production Market Share of Major Recombinant Human Insulin Manufacturers in 2014
Figure Europe Production Market Share of Major Recombinant Human Insulin Manufacturers in 2015
Figure Europe Sales Market Share of Major Recombinant Human Insulin Manufacturers in 2014
Figure Europe Sales Market Share of Major Recombinant Human Insulin Manufacturers in 2015
Figure Europe Sales (K Doses) and Growth Rate of Recombinant Human Insulin 2011-2016
Table Europe Supply, Consumption and Gap of Recombinant Human Insulin 2011-2016 (K Doses)
Table Europe Import, Export and Consumption of Recombinant Human Insulin 2011-2016 (K Doses)
Table Price of Europe Recombinant Human Insulin Major Manufacturers 2011-2016 (USD/Dose)
Table Gross Margin of Europe Recombinant Human Insulin Major Manufacturers 2011-2016
Table Europe and Major Manufacturers Revenue of Recombinant Human Insulin 2011-2016 (M USD)
Table Europe Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Recombinant Human Insulin 2011-2016
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Human Insulin Picture and Specifications of Novo Nordisk
Table Recombinant Human Insulin Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Recombinant Human Insulin Capacity (K Doses), Production (K Doses) and Growth Rate of Novo Nordisk 2011-2016
Figure Recombinant Human Insulin Production (K Doses) and Europe Market Share of Novo Nordisk 2011-2016
Table Novo Nordisk Recombinant Human Insulin SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Human Insulin Picture and Specifications of Eli Lilly
Table Recombinant Human Insulin Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
Figure Recombinant Human Insulin Capacity (K Doses), Production (K Doses) and Growth Rate of Eli Lilly 2011-2016
Figure Recombinant Human Insulin Production (K Doses) and Europe Market Share of Eli Lilly 2011-2016
Table Eli Lilly Recombinant Human Insulin SWOT Analysis
Table Bioton Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Human Insulin Picture and Specifications of Bioton
Table Recombinant Human Insulin Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bioton 2011-2016
Figure Recombinant Human Insulin Capacity (K Doses), Production (K Doses) and Growth Rate of Bioton 2011-2016
Figure Recombinant Human Insulin Production (K Doses) and Europe Market Share of Bioton 2011-2016
Table Bioton Recombinant Human Insulin SWOT Analysis
Table Dongbao Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Human Insulin Picture and Specifications of Dongbao
Table Recombinant Human Insulin Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dongbao 2011-2016
Figure Recombinant Human Insulin Capacity (K Doses), Production (K Doses) and Growth Rate of Dongbao 2011-2016
Figure Recombinant Human Insulin Production (K Doses) and Europe Market Share of Dongbao 2011-2016
Table Dongbao Recombinant Human Insulin SWOT Analysis
Table United Laboratories (TUL) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Human Insulin Picture and Specifications of United Laboratories (TUL)
Table Recombinant Human Insulin Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of United Laboratories (TUL) 2011-2016
Figure Recombinant Human Insulin Capacity (K Doses), Production (K Doses) and Growth Rate of United Laboratories (TUL) 2011-2016
Figure Recombinant Human Insulin Production (K Doses) and Europe Market Share of United Laboratories (TUL) 2011-2016
Table United Laboratories (TUL) Recombinant Human Insulin SWOT Analysis
Table Recombinant Human Insulin Price by Regions 2011-2016
Table Recombinant Human Insulin Price by Product Types 2011-2016
Table Recombinant Human Insulin Price by Companies 2011-2016
Table Recombinant Human Insulin Gross Margin by Companies 2011-2016
Table Price Comparison of Recombinant Human Insulin by Regions 2011-2016 (USD/Dose)
Table Price of Different Recombinant Human Insulin Product Types (USD/Dose)
Table Market Share of Different Recombinant Human Insulin Price Level
Table Gross Margin of Different Recombinant Human Insulin Applications
Table Marketing Channels Status of Recombinant Human Insulin
Table Traders or Distributors of Recombinant Human Insulin with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Recombinant Human Insulin (USD/Dose) in 2015
Table Europe Import, Export, and Trade of Recombinant Human Insulin (K Doses)
Figure Europe Capacity (K Doses), Production (K Doses) and Growth Rate of Recombinant Human Insulin 2016-2021
Figure Europe Capacity Utilization Rate of Recombinant Human Insulin 2016-2021
Table Europe Recombinant Human Insulin Production by Type 2016-2021 (K Doses)
Table Europe Recombinant Human Insulin Production Market Share by Type 2016-2021
Figure Europe Production Market Share of Recombinant Human Insulin by Type in 2021
Figure Europe Sales (K Doses) and Growth Rate of Recombinant Human Insulin 2016-2021
Figure Europe Sales Revenue (Million USD) and Growth Rate of Recombinant Human Insulin 2016-2021
Figure Europe Sales of Recombinant Human Insulin by Applications 2016-2021 (K Doses)
Table Europe Production Market Share of Recombinant Human Insulin by Applications 2016-2021
Figure Europe Production Market Share of Recombinant Human Insulin by Applications in 2021
Table Europe Production, Import, Export and Consumption of Recombinant Human Insulin 2016-2021 (K Doses)
Table Europe Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Recombinant Human Insulin 2016-2021
Table Major Raw Materials Suppliers of Recombinant Human Insulin with Contact Information
Table Manufacturing Equipment Suppliers of Recombinant Human Insulin with Contact Information
Table Major Players of Recombinant Human Insulin with Contact Information
Table Key Consumers of Recombinant Human Insulin with Contact Information
Table Supply Chain Relationship Analysis of Recombinant Human Insulin
Table New Project SWOT Analysis of Recombinant Human Insulin
Table New Project Investment Feasibility Analysis of Recombinant Human Insulin
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
